X4 Pharmaceuticals (XFOR) Leases (2019 - 2025)
Historic Leases for X4 Pharmaceuticals (XFOR) over the last 7 years, with Q3 2025 value amounting to $1.8 million.
- X4 Pharmaceuticals' Leases fell 6029.97% to $1.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.8 million, marking a year-over-year decrease of 6029.97%. This contributed to the annual value of $4.1 million for FY2024, which is 2805.31% down from last year.
- X4 Pharmaceuticals' Leases amounted to $1.8 million in Q3 2025, which was down 6029.97% from $2.6 million recorded in Q2 2025.
- Over the past 5 years, X4 Pharmaceuticals' Leases peaked at $9.8 million during Q1 2021, and registered a low of $1.8 million during Q3 2025.
- Its 5-year average for Leases is $6.3 million, with a median of $6.5 million in 2023.
- In the last 5 years, X4 Pharmaceuticals' Leases surged by 47360.1% in 2021 and then tumbled by 6029.97% in 2025.
- X4 Pharmaceuticals' Leases (Quarter) stood at $8.7 million in 2021, then fell by 17.0% to $7.2 million in 2022, then fell by 21.84% to $5.6 million in 2023, then fell by 28.05% to $4.1 million in 2024, then plummeted by 56.33% to $1.8 million in 2025.
- Its Leases was $1.8 million in Q3 2025, compared to $2.6 million in Q2 2025 and $3.7 million in Q1 2025.